QIAGEN N.V. provides sample to insight solutions that convert biological materials into molecular insights. Its customers include molecular diagnostics, academic institutions, pharmaceutical companies, and applied testing organizations. Revenue is generated from various segments: primary sample technology consumables (30-40%), secondary sample technology consumables (20-30%), instruments and accessories (20-30%), and bioinformatics solutions and services (10-20%). Factors supporting endurance include a diverse product range and established customer relationships, while potential limitations involve competition and reliance on regulatory approvals for its products.
—
QIAGEN N.V. provides sample to insight solutions that convert biological materials into molecular insights. Its customers include molecular diagnostics, academic institutions, pharmaceutical companies, and applied testing organizations. Revenue is generated from various segments: primary sample technology consumables (30-40%), secondary sample technology consumables (20-30%), instruments and accessories (20-30%), and bioinformatics solutions and services (10-20%). Factors supporting endurance include a diverse product range and established customer relationships, while potential limitations involve competition and reliance on regulatory approvals for its products.
—
Daily adjusted close
QIAGEN N.V. provides sample to insight solutions that convert biological materials into molecular insights. Its customers include molecular diagnostics, academic institutions, pharmaceutical companies, and applied testing organizations. Revenue is generated from various segments: primary sample technology consumables (30-40%), secondary sample technology consumables (20-30%), instruments and accessories (20-30%), and bioinformatics solutions and services (10-20%). Factors supporting endurance include a diverse product range and established customer relationships, while potential limitations involve competition and reliance on regulatory approvals for its products.